Curevac N.V. (CVAC)
$2.91
0.07 (2.35%)
CVAC Stock Quote Delayed 30 Minutes
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
349,054
Day's Range
$2.91 - $3.05
52-Week Range
$2.22 - $12.36
Dividend & Yield
N/A (N/A)
CVAC Stock Predictions, Articles, and Curevac N.V. News
CureVac (CVAC) Stock Rises 25% on Positive Data for Covid-19 and Flu Vaccines
CureVac announced positive results for its mRNA-based Covid-19 and flu vaccine, which may offer tremendous relevance for CVAC stock.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
We've got another busy day of trading ahead of us so let's get right to it with the biggest pre-market stock movers for Wednesday!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
We've got another busy day of trading ahead of us and we're starting with the biggest pre-market stock movers for Tuesday!
CVAC Stock Alert: Why Is Vaccine Maker CureVac Plunging Today?
Amid broadly bearish market sentiment, investors in CureVac and CVAC stock are in selling mode, as this stock receives a downgrade.
Vaccine Stocks: Why MRNA, VXRT, CVAC and NVAX Stocks Need a Band-Aid Today
Today, vaccine stocks are taking a massive hit as investors price in the potential effect of oral medications for Covid-19 on this sector.
Vaccine Stocks: The Latest News Moving BNTX, CVAC, NVAX Stocks Today
Today, investors in vaccine stocks are seeing a lot of red, as investors seem to be taking some risk off the table ahead of Fed tapering.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Good morning, investor! We're starting the day off with a deep dive into the biggest pre-market stock movers for Thursday!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Good morning! We're taking a look at the biggest pre-market stock movers for Wednesday and that includes the winners and losers.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's the final day of trading for the week and we're kicking it off right with a look at the pre-market stock movers for Friday!
What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.
So what did the stock market do today? All eyes were on a World Bank decision and big moves in RIDE and CVAC stocks.
CVAC Stock: The Huge Covid-19 News That Has CureVac Plunging Today
CureVac shares crashed after the German biotech said its Covid-19 vaccine was only 47% effective in preventing the disease.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
We're starting off the day with a look at the biggest pre-market stock movers for Thursday and it includes loads of medical stocks.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
We're really starting to get into earnings season with many of the biggest pre-market stock movers today connected to earnings news.
CVAC Stock: CureVac Pops on Plans for Phase 2 Vaccine Trials
CureVac just announced it was launching Phase 2 trials in Peru and Panama for its coronavirus vaccine. CVAC stock is rallying in response.
Germany Makes a $299 Million Bet on CureVac
CureVac recently was awarded $299 million to support the development of its Covid-19 vaccine. What does this mean for CureVac stock?
CureVac Stock Is Just Another Part of a Bigger Story
With its Covid-19 vaccine candidate, CureVac stock soared after its IPO in August. But as Operation Warp Speed wraps up, investors may wonder if there's anything else.
